Several studies suggested that TRIM29 promoted progression of cervical cancer18, pancreatic cancer19, colorectal cancer21, gastric cancer37, and glioma38, while suppressed progression of hepatocellular carcinoma via Wnt/beta-catenin signaling pathway22. The gene discussed is CTNNB1; the disease is hepatocellular carcinoma.